Comment
doi: 10.1016/j.eururo.2017.01.013.
Epub 2017 Jan 19.
Reply to Ye Lei, Serdar Yildiz, and Minfeng Chen's Letter to the Editor re: James J. Hsieh, David Chen, Patricia Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405-14
Affiliations
- PMID: 28111113
- DOI: 10.1016/j.eururo.2017.01.013
Item in Clipboard
Comment
Reply to Ye Lei, Serdar Yildiz, and Minfeng Chen's Letter to the Editor re: James J. Hsieh, David Chen, Patricia Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405-14
Eur Urol.
2017 Sep.
No abstract available
Comment on
-
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.Eur Urol. 2017 Mar;71(3):405-414. doi: 10.1016/j.eururo.2016.10.007. Epub 2016 Oct 15. Eur Urol. 2017. PMID: 27751729 Free PMC article.
-
Re: James J. Hsieh, David Chen, Patricia I. Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405-14.Eur Urol. 2017 Sep;72(3):e72-e73. doi: 10.1016/j.eururo.2017.01.012. Epub 2017 Jan 17. Eur Urol. 2017. PMID: 28108150 No abstract available.
Similar articles
-
Re: James J. Hsieh, David Chen, Patricia I. Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405-14.Eur Urol. 2017 Sep;72(3):e72-e73. doi: 10.1016/j.eururo.2017.01.012. Epub 2017 Jan 17. Eur Urol. 2017. PMID: 28108150 No abstract available.
-
Re: Nizar M. Tannir, Eric Jonasch, Laurence Albiges, et al. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN):A Randomized Multicenter Phase 2 Trial. Eur Urol 2016;69:866-74.Eur Urol. 2017 Jan;71(1):e23-e24. doi: 10.1016/j.eururo.2016.06.016. Epub 2016 Jun 22. Eur Urol. 2017. PMID: 27344295 No abstract available.
-
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.Eur Urol. 2016 May;69(5):866-74. doi: 10.1016/j.eururo.2015.10.049. Epub 2015 Nov 26. Eur Urol. 2016. PMID: 26626617 Free PMC article. Clinical Trial.
-
An update on targeted therapy in metastatic renal cell carcinoma.Urol Oncol. 2012 May-Jun;30(3):240-6. doi: 10.1016/j.urolonc.2009.12.018. Epub 2010 Apr 24. Urol Oncol. 2012. PMID: 20456985 Review.
-
Sunitinib for metastatic renal cell carcinoma.Future Oncol. 2010 Sep;6(9):1377-85. doi: 10.2217/fon.10.94. Future Oncol. 2010. PMID: 20919823 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
